Summary CryoLife, Inc. (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company's portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide diffuser, bovine pericardium, and mitral chordal repair products. It also offers contract manufacturing services in the therapeutic areas of cardiovascular and otrthopedic. CryoLife serves physicians, cardiac surgeons, hospitals, and healthcare facilities, among others. The company has manufacturing facilities in Texas and Georgia in the US. It has subsidiaries in the UK, Singapore, France, the US, and the Netherlands. The company distributes its products through its subsidiaries and independent distributors in the Middle East, and Africa, European Economic Area, Asia-Pacific and the Americas. CryoLife is headquartered in Atlanta, Georgia, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company CryoLife, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 CryoLife, Inc. Company Snapshot 5 CryoLife, Inc. Company Overview 5 CryoLife, Inc. Pipeline Products and Clinical Trials Overview 6 CryoLife, Inc. - Pipeline Analysis Overview 8 Business Description 8 Key Facts 9 CryoLife, Inc. - Major Products and Services 10 CryoLife, Inc. Pipeline Products by Development Stage 11 CryoLife, Inc. Pipeline Products Overview 13 Biodisc Nucleus Pulposus Replacement 13 Biodisc Nucleus Pulposus Replacement Product Overview 13 CryoValve SGAV 14 CryoValve SGAV Product Overview 14 PerClot 15 PerClot Product Overview 15 Synergraft Xenograft Heart Valve 16 Synergraft Xenograft Heart Valve Product Overview 16 Synergraft Xenograft Vascular Graft 17 Synergraft Xenograft Vascular Graft Product Overview 17 CryoLife, Inc. - Key Competitors 18 CryoLife, Inc. - Key Employees 19 CryoLife, Inc. - Key Employee Biographies 20 CryoLife, Inc. - Locations And Subsidiaries 21 Head Office 21 Other Locations & Subsidiaries 21 Recent Developments 22 CryoLife, Inc., Recent Developments 22 Apr 27, 2016: CryoLife Reports First Quarter 2016 Financial Results 22 Feb 15, 2016: CryoLife Reports Fourth Quarter and Full Year 2015 Financial Results 22 Nov 17, 2015: CryoLife Announces Resolution of PerClot Litigation with Medafor 23 Oct 27, 2015: CryoLife Reports Third Quarter Financial Results 24 Sep 08, 2015: CryoLife Appoints John Davis as Senior Vice President, Global Sales and Marketing 24 Jul 28, 2015: CryoLife Reports Second Quarter Financial Results 25 Jul 09, 2015: CryoLife Receives Expanded Indication for BioGlue in Japan 26 Jun 22, 2015: CryoLife to Transition to Direct Sales Model in France 26 May 20, 2015: On-X Life Technologies to Launch Chord-X Mitral Valve Chordal Repair System 26 Apr 28, 2015: CryoLife Reports First Quarter Results 27 Appendix 28 Methodology 28 About GlobalData 28 Contact Us 28 Disclaimer 28
List of Tables
CryoLife, Inc. Pipeline Products and Clinical Trials Overview 6 CryoLife, Inc. Pipeline Products by Equipment Type 6 CryoLife, Inc. Pipeline Products by Indication 7 CryoLife, Inc., Key Facts 9 CryoLife, Inc., Major Products and Services 10 CryoLife, Inc. Number of Pipeline Products by Development Stage 11 CryoLife, Inc. Pipeline Products Summary by Development Stage 12 Biodisc Nucleus Pulposus Replacement - Product Status 13 Biodisc Nucleus Pulposus Replacement - Product Description 13 CryoValve SGAV - Product Status 14 CryoValve SGAV - Product Description 14 PerClot - Product Status 15 PerClot - Product Description 15 Synergraft Xenograft Heart Valve - Product Status 16 Synergraft Xenograft Heart Valve - Product Description 16 Synergraft Xenograft Vascular Graft - Product Status 17 Synergraft Xenograft Vascular Graft - Product Description 17 CryoLife, Inc., Key Employees 19 CryoLife, Inc., Key Employee Biographies 20 CryoLife, Inc., Subsidiaries 21
List of Figures
CryoLife, Inc. Pipeline Products by Equipment Type 7 CryoLife, Inc. Pipeline Products by Development Stage 11
Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expeRead More...
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing iRead More...
Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliabRead More...
Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is antRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.